Works matching IS 03618609 AND DT 2022 AND VI 97 AND IP 3
Results: 31
Form follows function for freeze‐dried platelets.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 253, doi. 10.1002/ajh.26460
- By:
- Publication type:
- Article
Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E120, doi. 10.1002/ajh.26458
- By:
- Publication type:
- Article
Non‐coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E100, doi. 10.1002/ajh.26457
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 352, doi. 10.1002/ajh.26455
- By:
- Publication type:
- Article
Voxelotor use in adults with sickle cell disease in a real‐world setting.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E125, doi. 10.1002/ajh.26453
- By:
- Publication type:
- Article
TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 338, doi. 10.1002/ajh.26452
- By:
- Publication type:
- Article
Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 329, doi. 10.1002/ajh.26451
- By:
- Publication type:
- Article
Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E113, doi. 10.1002/ajh.26450
- By:
- Publication type:
- Article
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E117, doi. 10.1002/ajh.26449
- By:
- Publication type:
- Article
Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS‐RS) but not in MDS/MPN‐RS‐T.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E109, doi. 10.1002/ajh.26448
- By:
- Publication type:
- Article
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
- By:
- Publication type:
- Article
HLA 1–3 antigen‐mismatched related peripheral blood stem cells transplantation using low‐dose antithymocyte globulin versus unrelated cord blood transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 311, doi. 10.1002/ajh.26446
- By:
- Publication type:
- Article
The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 303, doi. 10.1002/ajh.26445
- By:
- Publication type:
- Article
A multicenter, retrospective study of accelerated venetoclax ramp‐up in patients with relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E105, doi. 10.1002/ajh.26444
- By:
- Publication type:
- Article
Thrombomodulin and multiorgan failure in sickle cell anemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E102, doi. 10.1002/ajh.26443
- By:
- Publication type:
- Article
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 274, doi. 10.1002/ajh.26442
- By:
- Publication type:
- Article
Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 293, doi. 10.1002/ajh.26441
- By:
- Publication type:
- Article
Increased blood viscosity and red blood cell aggregation in patients with COVID‐19.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 283, doi. 10.1002/ajh.26440
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E93, doi. 10.1002/ajh.26438
- By:
- Publication type:
- Article
Risk factors for severe COVID‐19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E86, doi. 10.1002/ajh.26432
- By:
- Publication type:
- Article
Venetoclax combined with FLAG‐based chemotherapy induces an early and deep response in mixed‐phenotype‐acute leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E91, doi. 10.1002/ajh.26436
- By:
- Publication type:
- Article
Diagnosis and management of new onset severe coagulopathy during after‐hours with thromboelastography.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 375, doi. 10.1002/ajh.26435
- By:
- Publication type:
- Article
Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E83, doi. 10.1002/ajh.26434
- By:
- Publication type:
- Article
Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin‐6 values in endotracheal and pleural fluids.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E81, doi. 10.1002/ajh.26433
- By:
- Publication type:
- Article
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
- By:
- Publication type:
- Article
The iron revolution: Keeping abreast of the developments in iron therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 250, doi. 10.1002/ajh.26427
- By:
- Publication type:
- Article
Freeze‐dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 256, doi. 10.1002/ajh.26403
- By:
- Publication type:
- Article
Eosinophil morphology in the reactive eosinophilia of Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 373, doi. 10.1002/ajh.26337
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 247, doi. 10.1002/ajh.26220
- Publication type:
- Article
A full set of mitotic phases in peripheral blood.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 383, doi. 10.1002/ajh.26169
- By:
- Publication type:
- Article